Trials / Conditions / Light Chain Amyloidosis
Light Chain Amyloidosis
5 registered clinical trials studyying Light Chain Amyloidosis — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory A NCT07081646 | Alexion Pharmaceuticals, Inc. | Phase 1 / Phase 2 |
| Recruiting | Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis NCT06971380 | Polina Stepensky | Phase 2 |
| Recruiting | Exploratory Clinical Study on the Safety and Efficacy of Targeted BCMA Autologous CART Cell Injection in Subje NCT06983951 | Beijing Boren Hospital | N/A |
| Recruiting | FKC288 for Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis NCT05978661 | Nanjing University School of Medicine | Phase 1 |
| Completed | Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis NCT01318902 | Millennium Pharmaceuticals, Inc. | Phase 1 |